Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography
The purpose of this study is to use a new imaging drug called 11C-choline that is used with a PET/CT scan to see prostate cancer when it cannot be seen well on other scans, such as bone scans, CT or MRI.
Study Start Date
Estimated Completion Date
- Device: PET/CT Scan
- Drug: 11C-choline
- Internal Medicine: Hematology/Oncology,Men’s Health,Nephrology/Urology
- Urology: Oncology,Prostate
- Family Medicine: Men`s Health,Urology
- Oncology: Renal/Urologic
- Physician Assistant: Hematology/Oncology,Urology
- Positron Emission Tomography
- Prostate Cancer
Memorial Sloan Kettering Cancer Center -- 15-117
Memorial Sloan Kettering Cancer Center
- Patient must have biopsy-proven adenocarcinoma of the prostate initially treated with curative intent (surgery and radiation therapy are most common treatments but other treatments are also eligible).
- Biochemical recurrence defined as any of the following: 1. PSA ? 0.2 ng/mL in at least two sequential tests for patients treated with surgery. 2. PSA ? 0.2 ng/mL above the post therapy nadir for patients treated with radiation therapy, brachytherapy or cryotherapy. 3. PSA ? 0.2 ng/ml above the most recent therapy nadir for patients who have received additional treatment in the recurrent setting
- Patient must have undergone standard-of-care restaging that does not clearly identify site(s) of active disease, or such prior studies must show equivocal findings for which further work-up is considered necessary to make clinical decision. Standard staging examinations may include one or more of the following: CT or MRI, bone imaging (either Tc-99m bisphosphonate scintigraphy MDP or F-18 sodium fluoride PET), or In-111 capromab pendetide scintigraphy no older than 3 months.
- Age ? 18 years.
- Patient must be able to tolerate PET/CT imaging.
- Patient must be able to understand and willing to sign a written informed consent document.
- Patient must not have claustrophobia that would preclude PET/CT imaging or other contraindications to CT imaging.
18 Years and older
Accepts Healthy Volunteers
Study Locations and Contact Information (1)
|Memorioal Sloan Kettering Cancer Center - New York, New York||50.7 miles||Heiko Schoder MD||212-639-2079||None|